Sopharma AD (WSE: SPH)
Poland flag Poland · Delayed Price · Currency is PLN
13.55
+1.05 (8.40%)
Jan 20, 2025, 1:33 PM CET

Sopharma AD Revenue

Sopharma AD had revenue of 543.31M BGN in the quarter ending September 30, 2024, with 17.45% growth. This brings the company's revenue in the last twelve months to 2.05B, up 12.18% year-over-year. In the year 2023, Sopharma AD had annual revenue of 1.89B with 12.95% growth.

Revenue (ttm)
2.05B BGN
Revenue Growth
+12.18%
P/S Ratio
n/a
Revenue / Employee
435.24K BGN
Employees
4,721
Market Cap
2.07B PLN

Revenue Chart

* This company reports financials in BGN.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.89B216.43M12.95%
Dec 31, 20221.67B60.17M3.73%
Dec 31, 20211.61B165.21M11.42%
Dec 31, 20201.45B158.02M12.27%
Dec 31, 20191.29B100.28M8.44%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.34B
Synektik Spólka Akcyjna 624.80M
Voxel 492.41M
Celon Pharma 209.54M
Selvita 334.42M
Ryvu Therapeutics 91.18M
Centrum Medyczne ENEL-MED 680.32M
Mercator Medical 488.78M
Revenue Rankings